Jason Wittes
Stock Analyst at Roth MKM
(3.42)
# 931
Out of 4,944 analysts
62
Total ratings
50%
Success rate
4.59%
Average return
Main Sectors:
Stocks Rated by Jason Wittes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SYK Stryker | Maintains: Buy | $405 → $456 | $375.53 | +21.43% | 11 | May 2, 2025 | |
| ALUR Allurion Technologies | Reiterates: Buy | $16 | $2.48 | +545.76% | 2 | Mar 21, 2025 | |
| MGRM Monogram Technologies | Maintains: Buy | $4 → $5.4 | $5.39 | +0.28% | 2 | Mar 18, 2025 | |
| FBIO Fortress Biotech | Reiterates: Buy | $15 → $16 | $1.94 | +724.74% | 3 | Mar 11, 2025 | |
| OFIX Orthofix Medical | Reiterates: Buy | $22 | $14.15 | +55.48% | 5 | Feb 26, 2025 | |
| IRMD IRADIMED CORPORATION | Reiterates: Buy | $60 → $72 | $72.20 | -0.28% | 3 | Feb 14, 2025 | |
| TLSI TriSalus Life Sciences | Reiterates: Buy | $11 | $3.56 | +208.99% | 2 | Jan 24, 2025 | |
| GMED Globus Medical | Maintains: Buy | $100 → $115 | $62.14 | +85.07% | 4 | Dec 17, 2024 | |
| MNMD Mind Medicine (MindMed) | Maintains: Buy | $36 | $10.19 | +253.29% | 1 | Jul 24, 2024 | |
| DERM Journey Medical | Reinstates: Buy | $11 | $7.30 | +50.68% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.18 | +747.46% | 1 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $100 | $94.93 | +5.34% | 1 | May 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $2.66 | +88.32% | 4 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $1.50 | +500.00% | 2 | Feb 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $29.56 | +153.72% | 2 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $15.86 | +38.71% | 3 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $120 | $102.34 | +17.26% | 7 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $206 | $154.76 | +33.11% | 1 | Sep 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $145 | $204.53 | -29.11% | 1 | Jun 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $12.80 | +17.19% | 2 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $200 | $11.57 | +1,628.61% | 3 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $26 | $27.62 | -5.87% | 1 | Feb 22, 2017 |
Stryker
May 2, 2025
Maintains: Buy
Price Target: $405 → $456
Current: $375.53
Upside: +21.43%
Allurion Technologies
Mar 21, 2025
Reiterates: Buy
Price Target: $16
Current: $2.48
Upside: +545.76%
Monogram Technologies
Mar 18, 2025
Maintains: Buy
Price Target: $4 → $5.4
Current: $5.39
Upside: +0.28%
Fortress Biotech
Mar 11, 2025
Reiterates: Buy
Price Target: $15 → $16
Current: $1.94
Upside: +724.74%
Orthofix Medical
Feb 26, 2025
Reiterates: Buy
Price Target: $22
Current: $14.15
Upside: +55.48%
IRADIMED CORPORATION
Feb 14, 2025
Reiterates: Buy
Price Target: $60 → $72
Current: $72.20
Upside: -0.28%
TriSalus Life Sciences
Jan 24, 2025
Reiterates: Buy
Price Target: $11
Current: $3.56
Upside: +208.99%
Globus Medical
Dec 17, 2024
Maintains: Buy
Price Target: $100 → $115
Current: $62.14
Upside: +85.07%
Mind Medicine (MindMed)
Jul 24, 2024
Maintains: Buy
Price Target: $36
Current: $10.19
Upside: +253.29%
Journey Medical
Jun 28, 2024
Reinstates: Buy
Price Target: $11
Current: $7.30
Upside: +50.68%
Jun 26, 2024
Initiates: Buy
Price Target: $10
Current: $1.18
Upside: +747.46%
May 31, 2024
Reinstates: Buy
Price Target: $100
Current: $94.93
Upside: +5.34%
Mar 5, 2024
Reiterates: Buy
Price Target: $5
Current: $2.66
Upside: +88.32%
Feb 13, 2024
Initiates: Buy
Price Target: $9
Current: $1.50
Upside: +500.00%
Oct 20, 2023
Initiates: Buy
Price Target: $75
Current: $29.56
Upside: +153.72%
Oct 20, 2023
Initiates: Buy
Price Target: $22
Current: $15.86
Upside: +38.71%
Oct 20, 2023
Initiates: Neutral
Price Target: $120
Current: $102.34
Upside: +17.26%
Sep 14, 2022
Initiates: Buy
Price Target: $206
Current: $154.76
Upside: +33.11%
Jun 27, 2022
Reinstates: Buy
Price Target: $145
Current: $204.53
Upside: -29.11%
Mar 3, 2022
Initiates: Buy
Price Target: $15
Current: $12.80
Upside: +17.19%
Feb 8, 2022
Initiates: Buy
Price Target: $200
Current: $11.57
Upside: +1,628.61%
Feb 22, 2017
Initiates: Buy
Price Target: $26
Current: $27.62
Upside: -5.87%